Source: Accesswire

Press Release: AGC Biologics : AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection

Read full article »
AGC Biologics's Competitors | AGC Biologics's News | AGC Biologics's Financials
Stay up-to-date with the latest news on AGC Biologics
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Alberto Santagostino's photo - President & CEO of AGC Biologics

President & CEO

Alberto Santagostino

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on AGC Biologics